Search for Bristol-Myers Squibb Co and
    1. NEW

      1:25PM

      Bristol-Myers Squibb misses mark with cancer drug

      Merck and Bristol-Myers Squibb have spent most of the past two years in a two-horse race to develop and sell...

    2. August 8, 2016

      Allergan setback prompts healthcare slide

      Healthcare stocks in the US slid on Monday in a lacklustre trading session as investors digested disappointing results...

    Special Reports

    1. Combating Cancer

      We consider the latest in cell therapy and efforts to arm the immune system in the fig...
    2. Corporate Longevity

      The FT launches a global investigation into the mixture of innovation and focus that c...
    Search more Special Reports on this topic.

    1. August 5, 2016

      Bristol-Myers’ value plunges as cancer drug fails

      A new blockbuster cancer drug Bristol-Myers Squibb hoped would become a replacement for chemotherapy in most lung...

    2. Fast FT

      August 5, 2016

      Bristol-Myers Squibb shares drop after trial results

      Shares in Bristol-Myers Squibb plummeted by 17 per cent in premarket trading, after its novel cancer drug failed in a...

    3. Fast FT

      July 28, 2016

      Bristol-Myers cancer drug sales increase sixfold

      Sales of a new cancer drug that turns the body into a weapon against the cancer cells increased by more than six-fold...

    4. June 2, 2016

      Brakes off in effort to confront melanoma

      Thanks to its terrible prognosis, melanoma was once known as the cancer that gave others a bad name. Now a type of...

    5. June 2, 2016

      President raises patient and business hope for cancer treatment

      When Jimmy Carter was diagnosed last year with melanoma that had spread to his brain, many people feared the worst for...

    6. May 9, 2016

      Pfizer to trial triple-combination cancer treatment

      Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make...

    7. April 26, 2016

      Tony Coles – on a mission to tackle Alzheimer’s

      After brokering the $10bn sale of the biotech company he led, Tony Coles planned to follow the well-trodden path of...

    8. March 21, 2016

      Jim Mellon-backed biotech to join Aim

      An experimental cancer drug discovered at Oxford university is the focus of a new UK biotech company to be listed in...

    9. March 8, 2016

      Bristol-Myers Squibb shakes up China operations to combat bribery

      Bristol-Myers Squibb has tightened rules on the way its sales representatives work with doctors in China after a $14m...

    10. February 1, 2016

      Investor calls for big pharma to slim down grow louder

      Some of the world’s biggest pharmaceuticals groups are facing calls to break up their diversified businesses in favour...

    11. January 31, 2016

      Gilead risks becoming victim of its own success

      During the past two years, Gilead, a California-based drugmaker, has emerged as the undisputed leader of the four large...

    12. January 22, 2016

      NHS approves £5,700-a-month skin cancer drug

      A groundbreaking new treatment for skin cancer has been given the go-ahead for use in the NHS after England’s drug cost...

    13. December 18, 2015

      GSK spends up to $1.5bn on HIV drugs in BMS deal

      GlaxoSmithKline has agreed to buy the HIV assets of Bristol-Myers Squibb for up to $1.5bn in the latest sign of...

    14. Fast FT

      December 18, 2015

      GlaxoSmithKline in deal to bulk up HIV treatments

      There appears to be no end to the pharmaceuticals deals that are being pushed through before the end of the year. Today...

    15. November 8, 2015

      Sanofi chief positive on new drugs as he warns on profits

      When Olivier Brandicourt took over as chief executive of Sanofi in April, there was a lot for him to be optimistic...

    16. October 6, 2015

      Bristol-Myers to pay SEC $14m to settle China bribery claim

      US drugmaker Bristol-Myers Squibb is to pay $14m in penalties to US authorities over alleged “improper payments” made...

    17. July 28, 2015

      Clinical trial data should be open to public view

      A much needed drive to open the results of clinical trials to public scrutiny is gathering momentum. Last week 85...

    18. July 12, 2015

      Drugmakers premiere summer blockbusters

      Blockbuster drugs are back. A wave of new multibillion-dollar medicines for heart disease and high cholesterol, added...

    19. June 5, 2015

      Cancer treatment: Healing powers

      It felt more like a gathering of Silicon Valley entrepreneurs than a mainstream medical meeting. But the 30,000...

    20. May 31, 2015

      Clinical trials show cancer drug combo boosts survival rate

      A combination of two “immunotherapy” medicines made by Bristol-Myers Squibb can dramatically improve the chances of...

    21. May 29, 2015

      Doctors hail new front in fight against cancer

      A novel class of drugs that turn the body into a weapon against tumours are set to be given to 60,000 of the sickest...

    22. May 29, 2015

      Novel cancer drugs tipped to boost drug sales

      In 1947, Sidney Farber, a pathologist working in a tiny hospital laboratory in Boston, gave an experimental cocktail of...

    23. May 15, 2015

      The drugs to watch in fight against cancer

      About 30,000 doctors and scientists will arrive in Chicago in two weeks for the annual meeting of the American Society...

    24. April 20, 2015

      Bristol-Myers combination melanoma treatment shows promise

      Skin cancer patients taking two Bristol-Myers Squibb drugs that help their immune systems fight melanoma saw their...

    25. April 13, 2015

      Biotech: Making sense of the science

      It was supposed to be a wonder drug. Provenge promised to turn the body’s immune system into a weapon against disease,...

    26. April 7, 2015

      Big pharma turns to small biotechs for edge in cancer treatment

      Partnerships between big pharma and small biotech companies have highlighted the scramble for assets in a new category...

    27. April 6, 2015

      US stock rise defies disappointing jobs data

      US stocks confounded expectations to push higher on Monday in their first trading session following last week’s...

    28. February 2, 2015

      Big pharmaceuticals groups faces biosimilars challenge

      Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

    29. January 15, 2015

      Healthcare: Counting the cost of cancer

      Anne Strange was too ill to dance at the evening reception when her daughter, Debbie, married in November but just...

    30. December 17, 2014

      Juno Therapeutics vies for cancer treatment lead

      When Juno Therapeutics lists on Nasdaq on Friday, it will be one of the biggest events in a big year for the buoyant US...

    31. December 8, 2014

      US sues Deutsche in $190m taxes claim

      Deutsche Bank and other firms are being pursued for more than $190m over allegedly setting up shell companies to avoid...

    32. December 1, 2014

      ‘Milestone’ in fight against Aids as treatment outpaces infections

      The world has passed an important tipping point in the fight against Aids, according to data showing that more people...

    33. September 26, 2014

      Drug development: Big pharma back in the game it made

      Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

    34. September 26, 2014

      Battling cancer: Focus turns to defence as best form of attack

      It has been described as the beginning of the end of cancer. A new wave of drugs that harnesses the body’s immune...

    35. August 4, 2014

      Bristol-Myers Squibb in venture to turn US research into drugs

      Allied Minds, a Boston-based science and technology development company, has joined forces with biopharmaceutical giant...

    36. July 31, 2014

      Drug pricing: Bitter pill

      When delegates turned up for a big healthcare conference at New York’s plush Waldorf Astoria hotel in February, they...

    37. July 27, 2014

      Hepatitis C researchers battle to ‘nuke’ the competition

      Idenix has fewer than 100 employees and no products on the market. So what was it that persuaded Merck to pay $3.85bn –...

    38. July 16, 2014

      Eli Lilly joins forces with UK biotech to develop cancer drugs

      Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill...

    Search for Bristol-Myers Squibb Co and